| CRISPR Medicine | This is an overview of our interviews
When clinicians at the Children’s Hospital of Philadelphia (CHOP) treated baby KJ – born with a rare, often-fatal urea-cycle disorder – with a CRISPR...
Scribe Therapeutics is preparing to take its first cardiometabolic programme into the clinic in mid-2026, positioning STX-1150 as a potentially...
A novel genome-editing platform addresses one of the field's most constant challenges – how to insert kilobase-scale DNA into living cells without...
With phase 1 data published today in The Lancet Microbe, SNIPR is positioning its experimental CRISPR–Cas-armed phage cocktail, SNIPR001, not simply...
A study published last week in Cell Stem Cell demonstrates for the first time that a topical, lipid nanoparticle-based gene editing approach can...
Circular DNA templates enable scalable gene insertion whilst preserving critical stem cell populations. Vice President Gene Therapy Julien Valton,...
Minutes ago, French and Italian researchers published a gene-editing strategy using adenine base editors to precisely repair two of the most common...
Researchers in Denmark report today in Nature Communications about novel deep learning models that significantly improve the accuracy of predicting...
